News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial     8/10/2016
FDA Bestows Novartis AG (NVS)'s Breast Cancer Pill With Breakthrough Tag     8/3/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin     7/21/2016
Galena Biopharma  (GALE) Craters and Discontinues Phase III Breast Cancer Vaccine NeuVax     6/30/2016
ASCO2016: Mylan (MYL)-BioCon (BIOCON.NS)'s Biosimilar Cancer Drug Comparable to Roche (RHHBY)'s Herceptin     6/6/2016
ASCO2016: Immunomedics (IMMU) Breast Cancer Abstract Booted from Conference     6/6/2016
Nektar Therapeutics (NKTR), DAIICHI SANKYO EUROPE GmbH Strike $80 Million+ ONZEALD Pact     6/1/2016
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance     5/31/2016
AstraZeneca PLC (AZN)'s Fulvestrant Meets Goals in Phase III Study     5/27/2016
SoCal's Puma Biotech (PBYI) Delays NDA for Neratinib to Treat Breast Cancer Until Mid-2016     3/29/2016
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015     3/24/2016
Breast Cancer Pipeline Has More than 1,000 Drugs in Development     3/9/2016
Immunomedics (IMMU)'s Breast Cancer Drug Wins Breakthrough Tag from the FDA     2/5/2016
NanoString (NSTG) Touts Collaborative Work in Immuno-Oncology at J.P. Morgan Conference     1/11/2016
Investors Await Four Key FDA Decisions in the First Quarter of 2016     1/5/2016

News from Around the Web
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
New Review Concludes Evidence For Alcohol Causing Cancer Is Strong, University Of Otago Study     7/22/2016
Got Dense Breasts? That Can Depend On Who Is Reading The Mammogram, University of Vermont Study     7/19/2016
Hops Extract Could Help Reduce Breast Cancer Risk, University of Illinois Study     7/12/2016
Why Do More Black Women Die of Breast Cancer? NIH Study     7/8/2016
NASA Technology Reveals Bacteria's Role In Breast Cancer     6/28/2016
In Mice, Daughters Of Overweight Dads Have Altered Breast Tissue, Higher Cancer Risk, Georgetown University Medical Center Study     6/27/2016
4 Things You Can Do To Decrease The Chance Your Breast Cancer Risk, Study Published In JAMA     6/3/2016
Breast Cancer Drug Found To Reduce Seizures, Northwestern University Study     5/24/2016
Eating Fatty Foods When Young May Up Your Breast Cancer Risk, University of Maryland Study     5/23/2016
Samsung Corporation Applies Deep Learning To Ultrasound Device     4/21/2016
ANGLE Device Able To Track Spread Of Breast Cancer, University of Southern California Study     4/20/2016
A Simple Diagnostic Blood Test For Breast Cancer, Macquarie University Reveals     3/24/2016
Pill That "Lights Up" Breast Cancer Could Lead To More Accurate Screening, University of Michigan Study     3/21/2016
New Technique To Battle Breast Cancer, University Of Peking Study     2/18/2016

Press Releases
ImmunoPhotonics Announces First Patient Dosed In A Randomized, Controlled Breast Cancer Clinical Trial For Incvax – A Novel Investigational Immuno-Oncology Therapy     8/23/2016
Puma Biotech (PBYI) Announces EMA Validation Of Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe     8/22/2016
Provista Diagnostics Release: New Study Integrating Multiple Types Of Protein Biomarkers Increases Accuracy Of Early Breast Cancer Detection     8/11/2016
Gamma Medica Release: Breakthrough Clinical Study Confirms Lumagem®’S Molecular Breast Imaging (MBI)’s High Cancer Detection Rate In Dense Breast Tissue Following Cancer-Negative Mammograms     8/1/2016
Puma Biotech (PBYI) Announces Interim 5-Year Disease Free Survival Data From Phase III Trial Of PB272 (Neratinib) In Extended Adjuvant HER2-Positive Early Stage Breast Cancer (Extenet Trial)     7/22/2016
Puma Biotech (PBYI) Submits New Drug Application For PB272 (Neratinib) To U.S. FDA For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer     7/22/2016
Accuray Inc. (ARAY) Release: TomoTherapy System Provides Favorable Cosmetic Outcomes Without Compromising Efficacy In Low-Risk Breast Cancer Patients     7/21/2016
NovoCure Snags FDA Approval for Second Generation Optune System     7/14/2016
Boehringer Ingelheim And Eli Lilly (LLY) Announce Clinical Trial Collaboration In Metastatic Breast Cancer     7/13/2016
BioNTech Release: Study Confirms Analytical Precision Of MammaTyper In Molecular Breast Cancer Typing     7/12/2016
Myriad Genetics (MYGN) Announces Positive Results For An Endopredict Clinical Study Published In The Journal Of The National Cancer Institute     7/11/2016
Puma Biotech (PBYI) Announces I-SPY 2 Phase II Study Of Neratinib Published In The New England Journal of Medicine     7/7/2016
Cascadian Therapeutics (ONTY) Receives ONT-380 Fast Track Designation From FDA For The Treatment Of Advanced HER2+ Metastatic Breast Cancer     6/29/2016
Puma Biotech (PBYI) Submits Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe     6/27/2016
Providence Health & Services Release: Study Finds Bacteria In Breast Ductal Fluid Milk Ducts Differs Between Healthy Women And Those With Breast Cancer History; Findings Show Microbes May Be Linked To Breast Cancer Development     6/24/2016

//-->